IL Trattamento Del Carcinoma Prostatico Avanzato: Confronto tra LHRH Analogo e Blocco Androgenico Totale

Boccardo F. , Decensi A. , Guarnieri D. : Long term results with a long-acting formulation of D - Trp 6 LHRH in patients with prostate cancer. First intern. symposium on advanced in urol. oncol. S. Remo 1987.

Faure N. , Lemay A. , Betal Laroche : Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma. Prostate, 4; 601–624 (1983).

Labrie F. , Dupont A. , Belanger A. : New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and our antiandrogen. J. Steroid. Biochem., 19; 999–1007 (1983).

Labrie F. , Dupont A. , Belanger A. : Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid. Biochem., 23; 833 (1985).

Labrie F. , Dupont A. , Belanger A. : New approach in the treatment of prostatic cancer: complete instead of only partial withdrawal of androgens. Prostate, 4; 579 (1983).

Labrie F. , Belanger A. , Dupont A : Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate. Lancet, 2; 1090 (1984).

Labrie F. , Dupont A. , Edmond J. , Monfette G. : Combination therapy in prostate cancer. Lancet, 2; 1095–1096 (1986).

Lefebvre F.A. , Seguin C. , Belanger A. : Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. Prostate, 3; 569 (1982).

Murphy G.P. , Greco J.M. , Chin J.L. : Clinical trial of new luteinizing hormone - releasing hormone analogue in metastatic prostatic carcinoma. Urology, 29; 185–190 (1987).

Presant C.A. , Soloway M.S. : Buserelin as primary therapy in advancaed prostatic carcinoma. Cancer, 56; 2146–2149 (1985).

Schröder F.H. : Total androgen suppression in the management of prostatic cancer. A critical review. In.: Schröder F.H. , Richards B. (edrs.) EORTC Genitourinary Group, monograph 2, p. 307–317, Liss, New York 1985.

Shally A.V. , Redding T.W. , Comarn-Schally A. M. : Inhibition of prostate tumours by agonistic and antagonistic analogs of LHRH. Prostate, 6; 174 (1985).

Smith J.A. , Glode L.M. , Wettlanfer J.N. : Clinical effects on gonodrophin - realising hormone analogue in metastatic carcinoma of the prostate. Urology, 25; 106 (1985).

Waxman J.A.H. , Hendry W.F. : Treatment with gonodotrophine releasing hormone analogue in advanced prostatic cancer. Brit. Med. J., 286; 1309–1312 (1983).